Printer Friendly

Browse Cancer metastasis topic

Drug therapy subtopic

Articles

1-300 out of 315 article(s) nextnext page
Title Author Type Date Words
CytoDyn requests initial meeting with FDA for Breakthrough Therapy status for leronlimab in treating cancer. Apr 4, 2020 472
InxMed (Shanghai) doses first patient in Phase Ib clinical trial of cancer drug IN10018. Mar 17, 2020 203
InxMed (Shanghai) doses first patient in Phase Ib clinical trial of cancer drug IN10018. Mar 17, 2020 199
Puma Biotechnology Receives US FDA Approval of Supplemental New Drug Application for Neratinib to Treat HER2-Positive Metastatic Breast Cancer. Feb 28, 2020 877
Metastatic Pancreatic Cancer Drug on Trial. Feb 1, 2020 224
Tazverik Approved to Treat Metastatic, Locally Advanced Epithelioid Sarcoma; Approval marks the first for a drug to treat this rare soft tissue sarcoma. Jan 24, 2020 243
Exceptional Response of Metastatic Chromophobe Renal Cell Carcinoma to Vascular Endothelial Growth Factor (VEGF) Inhibitors: Should Increased VEGF-C Expression Be Used to Guide Treatment? Bruinius, Jacob W.; Dykema, Karl J.; Noyes, Sabrina L.; Teh, Bin Tean; Lane, Brian R. Jan 1, 2020 3400
Isolated Testicular Metastasis Diagnosed More than a Decade and a Half Post Primary Treatment for Prostate Cancer. Abou Heidar, Nassib F.; Bustros, Gerges; Asmar, Jose M. El-; Zein Sabatto, Bassel; Degheili, Jad A. Dec 31, 2019 2758
Heat Shock Proteins in Cancer Immunotherapy. Das, Jugal Kishore; Xiong, Xiaofang; Ren, Xingcong; Yang, Jin-Ming; Song, Jianxun Dec 31, 2019 6814
AstraZeneca and Daiichi Sankyo's breast cancer treatment gets US approval. Dec 24, 2019 549
Seattle Genetics Submits Tucatinib New Drug Application to the US FDA for Patients with Locally Advanced or Metastatic HER2-Positive Breast Cancer. Dec 24, 2019 927
Enhertu (trastuzumab deruxtecan) approved in the US for HER2-positive unresectable or metastatic breast cancer following two or more prior anti-HER2 based regimens. Dec 23, 2019 1723
Enhertu Approved for Unresectable, Metastatic HER2+ Breast Cancer; Treatment indicated for patients who have received at least two previous anti-HER2-based regimens. Dec 23, 2019 271
Xtandi Approved by US FDA for the Treatment of Metastatic Castration-Sensitive Prostate Cancer. Dec 19, 2019 224
Pfizer Inc and Astellas Pharma Inc partnership wins FDA approval for sNDA for XTANDI to treat metastatic castrationsensitive prostate cancer. Dec 17, 2019 256
Pfizer Inc and Astellas Pharma Inc partnership wins FDA approval for sNDA for XTANDI to treat metastatic castrationsensitive prostate cancer. Dec 17, 2019 252
Two Drugs Make Inroads Against Aggressive Breast Cancers. Dec 11, 2019 1009
FDA approves Roche's Tecentriq plus chemotherapy (Abraxane and carboplatin) for the initial treatment of metastatic non-squamous non-small cell lung cancer. Dec 4, 2019 1548
Corrigendum to "Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience". Karivedu, Vidhya; Eldessouki, Ihab; Correa, Zelia; Taftaf, Ahmad; Zhu, Zheng; Makramalla, Abouelmagd Correction notice Nov 30, 2019 235
Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Sarcoma: A Multicenter, Retrospective Study. Narayanan, Prasad; Dattatreya, Palanki Satya; Prasanna, Rammohan; Subramanian, Sundaram; Jain, Kunal Report Nov 30, 2019 4394
CytoDyn's lead drug leronlimab inhibits colon carcinoma metastases to liver and lung in preclinical studies. Nov 20, 2019 626
CytoDyn reveals its drug inhibits colon carcinoma metastases to liver and lung in preclinical study. Nov 20, 2019 127
United States Metastatic Breast Cancer Treatment Market to 2025: Focus on Chemotherapy, Radiation Therapy, Biologic Targeted Therapy, Breast Surgery, Hormone Therapy. Nov 15, 2019 601
CytoDyn reports positive results from first patient in triple-negative breast cancer drug leronlimab trial. Clinical report Nov 13, 2019 613
IS TESTOSTERONE PROGNOSTIC IN PROSTATE CANCER TREATMENT? THE UROLOGICAL STANDPOINT/JE LI TESTOSTERON PROGNOSTICKI VAAN U LIJECENJU RAKA PROSTATE. UROLOSKO STAJALISTE. Soric, Tomislav; Vidic, Ivan Nov 1, 2019 2899
Severe Drug-Induced Liver Injury from Combination Encorafenib/Binimetinib. Gravbrot, Nicholas; Sundararajan, Srinath Oct 31, 2019 3010
Merck--Merck Receives Positive EU CHMP Opinion for Two New Regimens of KEYTRUDA[R] (pembrolizumab) as First-Line Treatment for Metastatic or Unresectable Recurrent Head and Neck Squamous Cell Carcinoma--18/10/2019. Oct 23, 2019 313
Propanc Biopharma plans to advance clinical trials on lead cancer drug PRP. Oct 22, 2019 409
Propanc Biopharma plans to advance clinical trials on lead cancer drug PRP. Oct 22, 2019 407
Merck & Company, Inc. (NYSE:MRK) - Merck Receives Positive EU CHMP Opinion for Two New Regimens of KEYTRUDA[R] (pembrolizumab) as First-Line Treatment for Metastatic or Unresectable Recurrent Head and Neck Squamous Cell Carcinoma -- 18/10/2019. Oct 21, 2019 282
Japan Pharmaceuticals Industry - Seattle Genetics and Astellas Announce Results from Phase 1 Trial of Investigational Agent Enfortumab Vedotin in Combination with Immune Therapy Pembrolizumab as First-Line Treatment for Advanced Bladder Cancer -- 28/9/2019. Oct 2, 2019 1246
CytoDyn's triple-negative breast cancer drug leronlimab given to first patient in clinical trial. Oct 1, 2019 362
Merck--Merck Receives Positive EU CHMP Opinion for Two New Regimens of KEYTRUDA[R] (pembrolizumab) as First-Line Treatment for Metastatic or Unresectable Recurrent Head and Neck Squamous Cell Carcinoma-18/10/2019. Oct 1, 2019 314
High Cervical Intrathecal Targeted Drug Delivery: A Case Report of Refractory Oropharyngeal Cancer Pain. Moman, Rajat N.; Rogers, Julie M.; Pittelkow, Thomas P. Report Sep 30, 2019 2302
Effects of MRgFUS Treatment on Musculoskeletal Pain: Comparison between Bone Metastasis and Chronic Knee/ Lumbar Osteoarthritis. Namba, Hirofumi; Kawasaki, Motohiro; Izumi, Masashi; Ushida, Takahiro; Takemasa, Ryuichi; Ikeuchi, M Sep 30, 2019 4854
CytoDyn has multiple shots on goal with its flagship drug leronlimab as cure for HIV, various cancers. Sep 20, 2019 1278
US FDA Accepts Supplemental New Drug Application for Neratinib to Treat HER2-Positive Metastatic Breast Cancer. Sep 16, 2019 585
Role of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Predictors Before Treatment for Metastatic Bladder Cancer Patients Receiving First-Line Chemotherapy. Bozkurt, Oktay; Dogan, Ender; Firat, Sedat Tank; Cosar, Ramazan; Inanc, Mevlude; Zararsiz, Gozde Ert Sep 1, 2019 4561
Lu-177 PSMA I&T Therapy for Prostate Cancer; Treatment Response, Treatment Toxicity, and Survival Results. Acar, Emine; Sonmezer, Burak; Derebek, Erkan; Bekis, Recep; Ozdogan, Ozhan; Kaya, Gamze Capa Sep 1, 2019 4547
Genentech (SIX: RO, ROG; OTCQX: RHHBY) - FDA Approves Genentech's Rozlytrek (entrectinib) for People With ROS1-Positive, Metastatic Non-Small Cell Lung Cancer and NTRK Gene Fusion-Positive Solid Tumors -- 15/8/2019. Aug 20, 2019 645
Tumor Infiltrating Lymphocytes Study, 2019: A New Frontier in Cancer Immunotherapy. Aug 20, 2019 597
Rozlytrek Approved to Treat Tumors With NTRK Gene Fusion; Drug also approved to treat metastatic non-small cell lung cancer with ROS1-positive tumors. Aug 19, 2019 327
FDA Approves Genentech's Rozlytrek for People with ROS1-Positive, Metastatic Non-Small Cell Lung Cancer and NTRK Gene Fusion-Positive Solid Tumors. Aug 19, 2019 982
FDA approves Roche's RozlytrekTM (entrectinib) for people with ROS1-positive, metastatic non-small cell lung cancer and NTRK gene fusion-positive solid tumours. Aug 16, 2019 1528
Correction - FDA approves Roche's Rozlytrek (entrectinib) for people with ROS1-positive, metastatic non-small cell lung cancer and NTRK gene fusion-positive solid tumours. Correction notice Aug 16, 2019 1748
Astellas Pharma Inc. - Astellas Submits Supplemental New Drug Application for Approval of Additional Indication of XTANDI[R] for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer in Japan -- 30/7/2019. Aug 2, 2019 331
Bayer wins FDA approval for Nubeqa to treat men with non-metastatic castration-resistant prostate cancer. Jul 31, 2019 278
Bayer wins FDA approval for Nubeqa to treat men with non-metastatic castration-resistant prostate cancer. Jul 31, 2019 274
Amgen (NASDAQ: AMGN) - Amgen And Allergan's MVASI[TM] (bevacizumab-awwb) And KANJINTI[TM] (trastuzumab-anns) Now Available In The United States -- 18/7/2019. Jul 25, 2019 757
New hope in treatment of cancer. Jul 23, 2019 140
Amgen (NASDAQ:AMGN) - Amgen And Allergan's MVASI[TM] (bevacizumab-awwb) And KANJINTI[TM] (trastuzumab-anns) Now Available In The United States -- 18/7/2019. Jul 22, 2019 743
Amgen, Allergan say Mvasi, Kanjinti now available in U.S. Jul 19, 2019 118
Eisai's Anticancer Agent Halaven Approved for Treatment of Locally Advanced or Metastatic Breast Cancer in China. Jul 17, 2019 687
Ipsen - Ipsen and Servier announce initial Phase 1/2 clinical data evaluating liposomal irinotecan (ONIVYDE[R]) as an investigational first-line treatment for metastatic pancreatic cancer at ESMO 21st World Congress on Gastrointestinal Cancer - 5/7/2019. Jul 11, 2019 524
Ipsen and Servier Release Initial Phase 1/2 Clinical Data Evaluating Liposomal Irinotecan as an Investigational First-line Treatment for Metastatic Pancreatic Cancer at ESMO 21st World Congress on Gastrointestinal Cancer. Jul 9, 2019 509
Puma Biotechnology Submits a Supplemental New Drug Application to US FDA for Neratinib to Treat HER2-Positive Metastatic Breast Cancer. Jul 8, 2019 910
Puma Biotechnology Submits a Supplemental New Drug Application to US FDA for Neratinib to Treat HER2-Positive Metastatic Breast Cancer. Jul 8, 2019 874
Pfizer Receives US FDA Approval for Its Oncology Biosimilar, Zirabev. Jul 2, 2019 322
Myocardial Infarction after Long-Term Treatment with a Tyrosine Kinase Inhibitor (TKI) with Anti-VEGF Receptor Activity. Paschke, L.; Lincke, T.; Muhlberg, K.; Lindner, Tom H.; Paschke, R. Jun 30, 2019 2036
Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC). Sheng, Iris Y.; Kruse, Megan; Leininger, Kathryn M.; Ornstein, Moshe C. Report Jun 30, 2019 882
Pfizer announces FDA approval for Zirabev for treatment of five types of cancer. Jun 28, 2019 102
FDA Approves US Merck's Keytruda as Monotherapy for Patients with Metastatic Small Cell Lung Cancer with Disease Progression on or After Platinum-Based Chemotherapy and at Least One Other Prior Line of Therapy. Jun 21, 2019 678
Merck--FDA Approves Merck's KEYTRUDA[R] (pembrolizumab) as Monotherapy for Patients with Metastatic Small Cell Lung Cancer (SCLC) with Disease Progression on or After Platinum-Based Chemotherapy and at Least One Other Prior Line of Therapy--18/6/2019. Jun 20, 2019 338
Amgen (NASDAQ: AMGN) - FDA Approves Amgen And Allergan's KANJINTI[TM] (trastuzumab-anns), A Biosimilar To Herceptin[R] (trastuzumab) -- 13/6/2019. Jun 18, 2019 1428
Immunotherapy in Prostate Cancer. Bolat, Deniz; Haydaroglu, Ayfer Jun 1, 2019 4730
Treating Penile Cancer in the Immunotherapy and Targeted Therapy Era. Hui, Gavin; Ghafouri, Sanaz N.; Shen, John; Liu, Sandy; Drakaki, Alexandra Apr 30, 2019 2542
Balversa Receives US FDA Approval for the Treatment of Patients with Locally Advanced or Metastatic Urothelial Carcinoma with Certain FGFR Genetic Alterations. Apr 15, 2019 887
US FDA Approves Ibrance for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer. Apr 9, 2019 472
Celgene says Tecentriq / Abraxane combo gets accelerated FDA approval for TNBC. Mar 12, 2019 269
Taiho Oncology wins US FDA approval for LONSURF to treat adult patients with metastatic gastric cancer. Feb 26, 2019 318
Taiho Oncology wins US FDA approval for LONSURF to treat adult patients with metastatic gastric cancer. Feb 26, 2019 314
Teva, Celltrion announce FDA approval of HERZUMA. Dec 14, 2018 119
FDA Approves Genentech's Tecentriq in Combination with Avastin and Chemotherapy for the Initial Treatment of People with a Specific Type of Metastatic Lung Cancer. Dec 11, 2018 624
Spirita Oncology Initiates a Phase 1 Clinical Trial of the Anti-Cancer Agent E6201 in Patients with Central Nervous System Metastases from BRAF+ or MEK-Mutated Metastatic Melanoma. Nov 28, 2018 387
New Data from Investigational Study of Lenvima and Keytruda Combination in Three Different Tumor Types Presented at the Society for Immunotherapy of Cancer's 33rd annual meeting. Nov 13, 2018 982
Eisai: New Data from Investigational Study of Lenvima (Lenvatinib) and Keytruda (Pembrolizumab) Combination in Three Different Tumor Types Presented at the Society for Immunotherapy of Cancer's 33rd Annual Meeting. Nov 9, 2018 1660
NantKwest announces results of haNK in novel cancer memory vaccine immunotherapy. Financial report Nov 7, 2018 299
FDA Approves US Merck's Keytruda in Combination with Carboplatin and Either Paclitaxel or Nab-Paclitaxel for the First-Line Treatment of Patients with Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC). Nov 2, 2018 353
Plasma-Based Genotyping Aids Targeted Tx of Metastatic NSCLC; Most patients who received targeted therapy based on plasma result achieved clinical response. Clinical report Oct 18, 2018 271
Sanofi Genzyme to market Libtayo for locally advanced or metastatic cutaneous squamous cell carcinoma upon US FDA approval. Oct 1, 2018 342
Sanofi Genzyme to market Libtayo for locally advanced or metastatic cutaneous squamous cell carcinoma upon US FDA approval. Oct 1, 2018 338
US FDA Approves Vizimpro for the First-Line Treatment of Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer. Oct 1, 2018 699
Icariin reduces human colon carcinoma cell growth and metastasis by enhancing p53 activities. Tian, Meili; Yang, Shuang; Yan, Xinpeng Report Oct 1, 2018 4588
Pfizer announces FDA approval for Vizimpro. Sep 27, 2018 265
Novel Immunotherapy May Up Survival in Melanoma Brain Mets; Findings in patients receiving checkpoint blockade immunotherapy for melanoma brain metastases. Sep 25, 2018 259
Janssen submits erdafitinib's NDA with the US FDA for the treatment of metastatic urothelial cancer. Sep 19, 2018 284
Janssen submits erdafitinib's NDA with the US FDA for the treatment of metastatic urothelial cancer. Sep 19, 2018 280
UNCOMMON SIDE EFFECTS OF SUNITINIB THERAPY IN A PATIENT WITH METASTATIC RENAL CELL CANCER: CASE REPORT. Separovic, Robert; Pavlovic, Mirjana; Silovski, Tajana; Silovski, Hrvoje; Vuger, Ana Tecic Clinical report Sep 1, 2018 1771
FDA Approves Expanded Label for US Merck's Keytruda in Combination with Pemetrexed (ALIMTA) and Platinum Chemotherapy for First-Line Treatment of Patients with Metastatic Nonsquamous NSCLC, with No EGFR or ALK Genomic Tumor Aberrations. Aug 23, 2018 155
Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel. Yokom, Daniel W.; Stewart, John; Alimohamed, Nimira S.; Winquist, Eric; Berry, Scott; Hubay, Stacey; Report Aug 1, 2018 6007
Pfizer reports FDA approves sNDA to broaden XTANDI indication. Jul 13, 2018 110
Sonali Bendre weeps as her long hair gets cut off ahead of cancer treatment; The actress revealed she was trying to remain positive after being diagnosed with metastatic cancer this month. Jul 11, 2018 372
Bristol-Myers' Opdivo approved for MSI-H/dMMR metastatic colorectal cancer. Jul 11, 2018 267
US FDA Approval Granted to Combination Braftovi with Mektovi for Metastatic Melanoma. Jul 2, 2018 194
Array BioPharma wins US FDA approval for BRAFTOVI & MEKTOVI combination for treating metastatic melanoma. Jun 28, 2018 266
Enzalutamide Improves Outcomes for Aggressive Prostate Cancer; Treatment led to 71 percent lower risk of metastasis or death compared to placebo. Jun 28, 2018 284
Metastatic Urothelial Cancer Drug Erdafitinib Yields Positive Results in Phase 2 Study. Clinical report Jun 8, 2018 271
Pfizer's Xalkori receives FDA breakthrough therapy designation in 2 indications. May 29, 2018 152
BBC presenter Rachael Bland reveals devastating 'incurable' cancer diagnosis and how trial drugs have 'turned her into a lab rat'; The You, Me and the Big C podcast co-host revealed she is taking a new trial drug after being told her cancer was metastatic. May 22, 2018 451
Oncolytics and FDA agree plan for phase 3 trial of metastatic breast cancer treatment. May 10, 2018 187
Oncolytics and FDA agree plan for phase 3 trial of metastatic breast cancer treatment. May 10, 2018 183
Debiopharm International SA passes US FDA Fast Track designation for Debio 1347 for treating metastatic tumours. May 9, 2018 207
Debiopharm International SA passes US FDA Fast Track designation for Debio 1347 for treating metastatic tumours. May 9, 2018 203
Roche's cancer immunotherapy TECENTRIQ (atezolizumab) granted FDA priority review for initial treatment of specific type of metastatic lung cancer. May 8, 2018 255
Roche's cancer immunotherapy TECENTRIQ (atezolizumab) granted FDA priority review for initial treatment of specific type of metastatic lung cancer. May 8, 2018 251
Zulekha uses new technique for cancer treatment. Apr 19, 2018 418
AstraZeneca says FDA approves Tagrisso as 1st-line treatment for certain cancers. Apr 19, 2018 106
Chemo, Immunotherapy Feasible in Metastatic Bladder Cancer; One-year overall survival of 61 percent for gemcitabine and cisplatin plus ipilimumab. Apr 11, 2018 267
Pfizer and Astellas Pharma submit supplemental New Drug Application to US FDA for Xtandi. Mar 21, 2018 229
Pfizer and Astellas Pharma submit supplemental New Drug Application to US FDA for Xtandi. Mar 21, 2018 225
Pfizer, Astellas Seek to Expand Indication of Xtandi to include Men with Non-metastatic CRPC. Mar 21, 2018 304
Neoadjuvant data promising, role unclear. Mar 1, 2018 313
Eli Lilly receives additional FDA approval for Verzenio. Feb 26, 2018 139
FDA Approves Erleada to Treat Non-Metastatic Prostate Cancer; First FDA-approved treatment for non-metastatic, castration-resistant prostate cancer. Feb 14, 2018 197
FDA GRANTS FAST TRACK DESIGNATION TO ANTI-HER2. Feb 1, 2018 878
Amgen and Allergan's MVASI (Biosimilar Bevacizumab) Approved by European Commission for Treatment of Certain Cancers. Jan 24, 2018 362
AstraZeneca wins US FDA expanded approval for Lynparza (olaparib tablets) to treat patients with germline susceptibility gene (BRCA) (HER2)-negative metastatic breast cancer. Jan 15, 2018 347
AstraZeneca wins US FDA expanded approval for Lynparza (olaparib tablets) to treat patients with germline susceptibility gene (BRCA) (HER2)-negative metastatic breast cancer. Jan 15, 2018 343
Personalized medicine offers new hope to breast cancer patients. Jan 1, 2018 2236
Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer. Yang, R.F.; Yu, B.; Zhang, R.Q.; Wang, X.H.; Li, C.; Wang, P.; Zhang, Y.; Han, B.; Gao, X.X.; Zhang, Report Jan 1, 2018 5456
Clinical outcomes of the sequential use of pazopanib followed by everolimus for the treatment of metastatic renal cell carcinoma: A multicentre study in Korea. Kim, Jeong Ho; Lee, Wan; Kim, Tae Nam; Nam, Jong Kil; Kim, Tae Hyo; Lee, Ki Soo Report Jan 1, 2018 3753
Case: Testicular oligometastasis from prostate cancer--Report of rare isolated recurrence after radiotherapy and intermittent androgen-deprivation therapy. Cho, Chan-Kyung J.; Sigurdson, Samantha; Davidson, Christopher M.; Leveridge, Michael; Mahmud, Aamer Clinical report Jan 1, 2018 1729
Cyclin-Dependent Kinase 4/6 Inhibitor (Palbociclib) Induced Aplastic Anemia in a Patient with Metastatic Breast Cancer. Nwabudike, Stanley Madu; Edwards, Camille V.; Akinboro, Oladimeji; Quinn, Kathryn; Sarosiek, Shayna; Jan 1, 2018 2669
Natural Products as a Source for New Leads in Cancer Research and Treatment. Cabral, Celia; Efferth, Thomas; Pires, Isabel M.; Severino, Patricia; Lemos, Marco F.L. Jan 1, 2018 805
A Systematic Review and Pooled Analysis of Studies of Oral Etoposide in Metastatic Breast Cancer. Voutsadakis, Ioannis A. Report Jan 1, 2018 5289
Treatment of Sarcoma Lung Metastases with Stereotactic Body Radiotherapy. Lindsay, Adam D.; Haupt, Edward E.; Chan, Chung M.; Spiguel, Andre R.; Scarborough, Mark T.; Zloteck Disease/Disorder overview Jan 1, 2018 3436
Immunotherapy in Advanced Gastric Cancer: An Overview of the Emerging Strategies. Magalhaes, Helena; Fontes-Sousa, Mario; Machado, Manuela Jan 1, 2018 5468
Combination Immunotherapy Approaches for Pancreatic Cancer Treatment. Cheng, Xianliang; Zhao, Gang; Zhao, Yunqi Jan 1, 2018 5627
The Potential Role of Liver Transplantation as a Treatment Option in Colorectal Liver Metastases. Line, Pal-Dag; Hagness, Morten; Dueland, Svein Jan 1, 2018 3982
Metastatic Colorectal Cancer in the Era of Personalized Medicine: A More Tailored Approach to Systemic Therapy. Yu, Irene S.; Cheung, Winson Y. Jan 1, 2018 10321
Differential Regulation of Methylation-Regulating Enzymes by Senescent Stromal Cells Drives Colorectal Cancer Cell Response to DNA-Demethylating Epi-Drugs. Agrawal, Khushboo; Das, Viswanath; Taborska, Natalie; Gursky, Jan; Diubak, Petr; Hajduch, Marian Jan 1, 2018 7539
Efficacy of Nivolumab in a Patient with Metastatic Renal Cell Carcinoma and End-Stage Renal Disease on Dialysis: Case Report and Literature Review. Ansari, Jawaher; Ali, Muhammad; Farrag, Ashraf; Ali, Arwa M.; Alhamad, Abdulaziz Jan 1, 2018 2518
Effective Immunotherapy in Bone Marrow Metastatic Melanoma Presenting with Disseminated Intravascular Coagulopathy. Gbadamosi, Bolanle; Ezekwudo, Daniel; Nayak, Bhadresh; Yu, Zhou; Gjorgova-Gjeorgjievski, Sandra; Xie Jan 1, 2018 5024
Erratum to "Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy". Genova, Pietro; Sorce, Maria; Cabibi, Daniela; Genova, Gaspare; Gebbia, Vittorio; Galanti, Daniele; Correction notice Jan 1, 2018 228
GNQ-209P Mutation in Metastatic Uveal Melanoma and Treatment Outcome. Karim, Nagla Abdel; Eldessouki, Ihab; Taftaf, Ahmad; Ayham, Deeb; Gaber, Ola; Makramalla, Abouelmagd Jan 1, 2018 3014
Immunotherapy for Metastatic Melanoma with Right Atrial Involvement in a Patient with Rheumatoid Arthritis. Benson, Zachary; Gordon, Sarah; Nicolato, Patricia; Poklepovic, Andrew Jan 1, 2018 2067
PTHlR-CaSR Cross Talk: New Treatment Options for Breast Cancer Osteolytic Bone Metastases. Yang, Yanmei; Wang, Bin Jan 1, 2018 6228
Janssen Biotech passes the US FDA's priority review designation for the New Drug Application (NDA) for apalutamide for prostate cancer. Dec 22, 2017 282
Janssen Biotech passes the US FDA's priority review designation for the New Drug Application (NDA) for apalutamide for prostate cancer. Dec 22, 2017 278
Preclinical Data Show Agilvax AX09 Immunotherapy Reduces Tumor Growth and Pulmonary Metastases in Triple Negative Breast Cancer. Dec 7, 2017 252
Metastatic Breast Cancer Treatment. Brief article Sep 22, 2017 222
Madison Vaccines Doses First Patient in Trial of MVI-816 Plus Keytruda for Metastatic, Treatment-Resistant Prostate Cancer. Aug 4, 2017 308
New drug 'cuts cancer tumours by up to half'. Aug 3, 2017 170
Radiation therapy--an effective tool for analgesia in metastatic bone disease in breast cancer. Negi, Preety; Kingsley, Pamela Alice; Sachdeva, Jaineet; Srivastava, Himanshu Report Jul 31, 2017 2888
Neon Therapeutics, Apexigen to Collaborate in Clinical Trial for Metastatic Melanoma Treatment. Jul 26, 2017 289
US FDA Approves Bristol-Myers Squibb's Yervoy for Treatment of Adolescents with Unresectable or Metastatic Melanoma. Jul 25, 2017 470
Future Cancer Treatment Could Stop Disease From Spreading. Jul 3, 2017 574
Renal salt wasting syndrome in a patient receiving cisplatin chemotherapy for metastatic testicular cancer: a case report. Anderson, Christine; Linington, Ashley Clinical report Jul 1, 2017 3118
Effectiveness and safety of percutaneous vertebroplasty in the treatment of spinal metastatic tumor. Jun 30, 2017 3036
REGULATORY METASTASIS: ALTERING THE REGULATORY AND PAYER LANDSCAPE TO CHANGE THE LIVES OF CANCER PATIENTS. Camiel, Adam J. Jun 22, 2017 22548
OncoSec wins US FDA's orphan drug designation for tavokinogene telsaplasmid to treat unresectable metastatic melanoma. Jun 9, 2017 253
Array BioPharma, Bristol-Myers Squibb Partner to Study Treatment Regimen for Metastatic Colorectal Cancer. Jun 5, 2017 355
Novartis wins US FDA approval to expand use of Zykadia for treating patients with metastatic non-small cell lung cancer. May 29, 2017 278
Novartis wins US FDA approval to expand use of Zykadia for treating patients with metastatic non-small cell lung cancer. May 29, 2017 274
Pfizer Inc announces US FDA approval of BAVENCIO (avelumab) for Advanced Bladder Cancer; Its second approval in less than two months. May 10, 2017 285
Pfizer Inc announces US FDA approval of BAVENCIO (avelumab) for Advanced Bladder Cancer; Its second approval in less than two months. May 10, 2017 281
FDA Approves US Merck's Keytruda as First-Line Combination Therapy with Pemetrexed and Carboplatin for Patients with Metastatic Nonsquamous Non-Small Cell Lung Cancer, Irrespective of PD-L1 Expression. May 10, 2017 390
FDA approves first treatment for metastatic Merkel cell. Nikolaides, Laura May 1, 2017 341
Comparative effect of Maitake Pro4x with Chemotherapy breast cancer treatment. Braico, Diego Aguilera; Roldan-Deamicis, Agustina; Brie, Belen; Balogh, Gabriela Andrea Report May 1, 2017 5426
US FDA Grants Breakthrough Therapy Designation to Pfizer's Lorlatinib Next-Generation ALK/ROS1 Inhibitor for ALK-Positive Metastatic Non-Small Cell Lung Cancer. Apr 27, 2017 355
Erytech publishes positive phase 2b data for eryaspase, a treatment for metastatic pancreatic cancer. Mar 27, 2017 292
Erytech publishes positive phase 2b data for eryaspase, a treatment for metastatic pancreatic cancer. Mar 27, 2017 288
Pfizer Inc wins US FDA approval for BAVENCIO (avelumab) to treat metastatic merkel cell carcinoma. Mar 24, 2017 306
Pfizer Inc wins US FDA approval for BAVENCIO (avelumab) to treat metastatic merkel cell carcinoma. Mar 24, 2017 302
Delhi High Court gives Biocon, Mylan green light to sell biosimilar cancer drug. Mar 3, 2017 267
Delhi High Court gives Biocon, Mylan green light to sell biosimilar cancer drug. Mar 3, 2017 263
Bristol-Myers Squibb passes US FDA approval for Opdivo for treating metastatic urothelial carcinoma. Feb 3, 2017 276
Bristol-Myers Squibb passes US FDA approval for Opdivo for treating metastatic urothelial carcinoma. Feb 3, 2017 272
Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System. Bai, Yongrui; Xu, Yuejuan; Wu, Bin Report Jan 1, 2017 4331
Effects of Combined Simultaneous and Sequential Endostar and Cisplatin Treatment in a Mice Model of Gastric Cancer Peritoneal Metastases. Jia, Lin; Ren, Shuguang; Li, Tao; Wu, Jianing; Zhou, Xinliang; Zhang, Yan; Wu, Jianhua; Liu, Wei Report Jan 1, 2017 4337
Hyaluromycin, a Novel Hyaluronidase Inhibitor, Attenuates Pancreatic Cancer Cell Migration and Proliferation. Kohi, Shiro; Sato, Norihiro; Koga, Atsuhiro; Hirata, Keiji; Harunari, Enjuro; Igarashi, Yasuhiro Report Jan 1, 2017 2884
Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs. Fulkerson, Christopher M.; Dhawan, Deepika; Ratliff, Timothy L.; Hahn, Noah M.; Knapp, Deborah W. Report Jan 1, 2017 7843
The Differential Contribution of the Innate Immune System to a Good Pathological Response in the Breast and Axillary Lymph Nodes Induced by Neoadjuvant Chemotherapy in Women with Large and Locally Advanced Breast Cancers. Kaewkangsadan, Viriya; Verma, Chandan; Eremin, Jennifer M.; Cowley, Gerard; Ilyas, Mohammad; Satthap Report Jan 1, 2017 15041
A Comprehensive Review of US FDA-Approved Immune Checkpoint Inhibitors in Urothelial Carcinoma. Hsu, Fu-Shun; Su, Chun-Hung; Huang, Kou-How Jan 1, 2017 5500
Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies? Bossi, Paolo; Siano, Marco; Bergamini, Cristiana; Rocca, Maria Cossu; Sponghini, Andrea P.; Giannocc Report Jan 1, 2017 5300
Uncommon BRAF Mutations Associated with Durable Response to Immunotherapy in Patients with Metastatic Melanoma. Swofford, Brenen P.; Homsi, Jade Report Jan 1, 2017 2178
Complex Monitoring of Biochemical and Radionuclide Parameters in Patients with Metastatic Renal Cell Carcinoma during Immunotherapy. Sayapina, M.S.; Averinova, S.G.; Zacharova, T.V.; Kashkadaeva, A.V.; Shiryaev, S.V.; Poluectova, M.V Jan 1, 2017 5461
Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives. Zichi, Clizia; Tucci, Marcello; Leone, Gianmarco; Buttigliero, Consuelo; Vignani, Francesca; Pignata Report Jan 1, 2017 9562
The eIF4E2-Directed Hypoxic Cap-Dependent Translation Machinery Reveals Novel Therapeutic Potential for Cancer Treatment. Melanson, Gaelan; Timpano, Sara; Uniacke, James Report Jan 1, 2017 9118
Efficacy of Juzentaihoto for Tumor Immunotherapy in B16 Melanoma Metastasis Model. Ishikawa, Shintaro; Ishikawa, Takako; Tezuka, Chiaki; Asano, Kazuhito; Sunagawa, Masataka; Hisamitsu Jan 1, 2017 4952
U.K. NICE Recommends Anticancer Agent Halaven as Treatment for Advanced Breast Cancer. Nov 4, 2016 1190
Genentech, a member of the Roche Group, received approval from the FDA for TECENTRIQ (atezolizumab) for the treatment of metastatic non-small cell lung cancer (NSCLC) who have disease progression during or following chemotherapy, and have progressed on another targeted therapy if their tumor has EGFR or ALK gene abnormalities. Nov 1, 2016 172
amcure announces initiation and first patient treated in a Phase I/Ib clinical study of AMC303 for cancer treatment. Clinical report Oct 27, 2016 314
amcure announces initiation and first patient treated in a Phase I/Ib clinical study of AMC303 for cancer treatment. Clinical report Oct 27, 2016 310
Study: Antioxidants in Antidiabetic Drugs May Fuel Cancer Spread. Apr 15, 2016 305
Eisai Receives Positive CHMP Opinion on New Indicator for Anticancer Agent Halaven for Treatment of Advanced Liposarcoma. Apr 5, 2016 1544
Pfizer wins US FDA's approval for sNDA for XALKORI for treating patients with ROS1-positive metastatic NSCLC. Mar 14, 2016 328
Pfizer wins US FDA's approval for sNDA for XALKORI for treating patients with ROS1-positive metastatic NSCLC. Mar 14, 2016 324
Eisai Submits New Application in Europe for In-House Developed Anticancer Agent Lenvatinib Seeking Approval for Indication Covering Renal Cell Carcinoma. Jan 12, 2016 1223
Eli Lilly and Company wins US FDA's approval for Portrazza for first-line treatment of metastatic squamous non-small cell lung cancer. Nov 25, 2015 284
Eli Lilly and Company wins US FDA's approval for Portrazza for first-line treatment of metastatic squamous non-small cell lung cancer. Nov 25, 2015 280
Bristol-Myers Squibb Co. received approval from the FDA for Opdivo (nivolumab) in combination with Yervoy (ipilimumab), for the treatment of patients with BRAFV600 wild-type unresectable or metastatic melanoma. Nov 1, 2015 185
Docetaxel extends survival in metastatic prostate ca. Nelson, Roxanne Sep 15, 2015 690
Metastatic renal cell cancer: summary from ASCO 2015. Conference notes Aug 1, 2015 2447
Bristol-Myers Squibb wins US FDA approval for Opdivo (nivolumab) for treating metastatic melanoma. Dec 23, 2014 119
Bristol-Myers Squibb wins US FDA approval for Opdivo (nivolumab) for treating metastatic melanoma. Dec 23, 2014 115
Bone marrow metastasis of prostatic adenocarcinoma with post-treatment foamy-like changes: a diagnostic pitfall. Yigit, Nuri; Geyer, Julia Turbiner Case study Dec 1, 2014 1854
Multiple metastases from ovarian cancer. Singh, D.; Kapoor, A.; Jakhar, S.L.; Bagri, P.K.; Kumar, H.S. Report Oct 1, 2014 1449
Merck wins accelerated approval from the US FDA for KEYTRUDA for unresectable or metastatic melanoma. Sep 5, 2014 235
Merck wins accelerated approval from the US FDA for KEYTRUDA for unresectable or metastatic melanoma. Sep 5, 2014 231
First ever treatment to prevent tumor metastasis revealed. Jul 25, 2014 127
Canadian content at GU-ASCO 2014: Highlights of research involving Canadian researchers. Kapoor, Anil Conference notes Mar 1, 2014 2105
Molecular targeted approaches for advanced BRAF V600, N-RAS, c-KIT, and GNAQ melanomas. Giovanni, Ponti; Giovanni, Pellacani; Aldo, Tomasi; Pietro, Loschi; Gabriele, Luppi; Fabio, Gelsomin Report Jan 1, 2014 1755
Targeting angiogenesis and tumor microenvironment in metastatic colorectal cancer: role of aflibercept. Giordano, Guido; Febbraro, Antonio; Venditti, Michele; Campidoglio, Serena; Olivieri, Nunzio; Raieta Report Jan 1, 2014 8558
Efficacy of adding bevacizumab in the first-line chemotherapy of metastatic colorectal cancer: evidence from seven randomized clinical trials. Chen, Yan-xian; Yang, Qiong; Kuang, Jun-jie; Chen, Shi-yu; Wei, Ying; Jiang, Zhi-min; Xie, De-rong Report Jan 1, 2014 4828
Endovascular treatment of vertebral column metastases using intra-arterial cisplatin: pilot experience. Chopko, Bohdan W. Case study Jan 1, 2014 1491
Pfizer Inc wins US FDA's regular approval for XALKORI for patients with metastatic ALK-positive non-small cell lung cancer. Nov 22, 2013 235
Pfizer Inc wins US FDA's regular approval for XALKORI for patients with metastatic ALK-positive non-small cell lung cancer. Nov 22, 2013 231
US FDA grants Priority Review to SmithKline for dabrafenib/trametinib combination in metastatic melanoma. Sep 16, 2013 178
US FDA grants Priority Review to SmithKline for dabrafenib/trametinib combination in metastatic melanoma. Sep 16, 2013 174
Mucinous breast cancer with solitary metastasis to humeral head: a case report. Alajmi, Adil Aljarrah; Hashmi, Maryam Al-; Malik, Kamran Ahmad; Sukhpal, Sawhney; Hussein, Samir; Ri Clinical report Sep 1, 2013 1771
Complete response to low-dose sorafenib in a patient with metastatic renal cell carcinoma: A case report. Morita, Jun; Naoe, Michio; Ogawa, Yu; Nakasato, Takehiko; Sugahara, Motoko; Morita, Masashi; Fuji, K Clinical report May 1, 2013 2385
Possible drug target to stop breast cancer metastasis identified. Jan 28, 2013 371
Exelixis Inc unveils US FDA approved COMETRIQ in the US for metastatic medullary thyroid cancer. Jan 25, 2013 156
Exelixis Inc unveils US FDA approved COMETRIQ in the US for metastatic medullary thyroid cancer. Jan 25, 2013 152
Ipilimumab: a first-in-class T-cell potentiator for metastatic melanoma. Chmielowski, Bartosz Report Jan 1, 2013 5548
A full GMP process to select and amplify epitope-specific T lymphocytes for adoptive immunotherapy of metastatic melanoma. Labarriere, N.; Fortun, A.; Bellec, A.; Khammari, A.; Dreno, B.; Saiagh, S.; Lang, F. Jan 1, 2013 6938
Debiopharm Group unveils Pamorelin LA in India for the treatment of prostate cancer. Dec 10, 2012 194
Debiopharm Group unveils Pamorelin LA in India for the treatment of prostate cancer. Dec 10, 2012 190
Ginsenoside: novel agent for breast cancer? Dec 1, 2012 549
Clovis Oncology reports disappointing results from testing of pancreatic cancer drug. Nov 12, 2012 200
Clovis Oncology reports disappointing results from testing of pancreatic cancer drug. Nov 12, 2012 196
Low-dose Thalidomide in patients with Metastatic Renal Cell Carcinoma. Tunio, Mutahir Ali; Hashmi, Altaf; Qayyum, Rehan Masood Abdul; Naimatullah, Najeeb Report Sep 30, 2012 2783
Eisai Receives Approval to Market Anticancer Agent Halaven(R) in Australia. Sep 7, 2012 1138
Medivation Inc & Astellas Pharma Inc receives US FDA's approval for XTANDI for patients with metastatic castration-resistant prostate cancer. Sep 3, 2012 168
Medivation Inc & Astellas Pharma Inc receives US FDA's approval for XTANDI for patients with metastatic castration-resistant prostate cancer. Sep 3, 2012 164
Delcath Systems Inc files NDA with US FDA for proprietary chemosaturation system to treat patients with unresectable metastatic melanoma in the liver. Aug 16, 2012 168
Delcath Systems Inc files NDA with US FDA for proprietary chemosaturation system to treat patients with unresectable metastatic melanoma in the liver. Aug 16, 2012 164
Qiagen Diagnostic Approved for Colorectal Cancer*. Aug 1, 2012 1081
Bristol-Meyers Squibb and Eli Lilly announce FDA approval of ERBITUX. Jul 9, 2012 254
New candidate drug stops cancer metastasis and regenerates nerve cells. Jun 22, 2012 721
HIV drug `may slow down metastatic breast cancer`. Jun 7, 2012 557
Intermittent therapy inferior to hormone therapy for prostrate cancer. Jun 4, 2012 801
New Drug Slows Advanced Prostate Cancer. Clinical report Jun 4, 2012 781
FDA grants review for cancer drug from Sanofi. Apr 5, 2012 123
Beta - blockers may help with breast cancer treatment: may help prevent heart failure and death from metastatic disease. Apr 1, 2012 468
Consolidative high-dose chemotherapy after conventional-dose chemotherapy as first salvage treatment for male patients with metastatic germ cell tumours. Beausoleil, Michel; Ernst, D. Scott; Stitt, Larry; Winquist, Eric Report Apr 1, 2012 3536
New melanoma drug may accelerate secondary skin cancers. Mar 1, 2012 164
Researchers take a new look at ovarian cancer treatment. Jan 18, 2012 399
Targeted therapies in breast cancer: tailoring treatment to the molecular drivers of disease progression. Hicks, David G. Report Jan 1, 2012 1909
Avastin approval for breast cancer treatment revoked by FDA. Jan 1, 2012 137
NICE says no to AstraZeneca's breast cancer drug Faslodex. Dec 15, 2011 163
Health Canada approves Eisai's anticancer agent Halaven. Dec 15, 2011 161
Eisai Announces Canadian Approval of its Anticancer Agent Halaven. Dec 15, 2011 494
Chemotherapy to the liver delays progression of metastatic melanoma. McBride, Deborah Brief article Dec 1, 2011 264
FDA revokes Avastin approval for breast cancer. Mechcatie, Elizabeth Dec 1, 2011 615
Erbitux (cetuximab) gets FDA approval for metastatic head and neck cancer. Nov 8, 2011 351
Drug combo prolongs progression-free survival time in breast cancer. Sep 26, 2011 293
Antibody-guided drug 'delays breast cancer progression in trials'. Sep 25, 2011 247
Roche to report new results for cancer treatments. Financial report Sep 19, 2011 151
Pfizera[euro](tm)s XALKORI receives US FDA approval for lung cancer treatment. Aug 29, 2011 347
Qiagen completes second FDA submission for KRAS RGQ PCR Kit. Aug 5, 2011 211
Drug combo can benefit more than 1 in 3 with hard-to-treat breast cancer. Jul 9, 2011 252
New drug shows promise in stopping prostate cancer spread to bone. Jun 8, 2011 270
Zeltia begins studies of pancreatic cancer treatment drug. Jun 8, 2011 134
AstraZeneca's orphan drug vandetanib receives FDA approval. Apr 7, 2011 267
A case in which a combination of natural compounds was effective in metastatic breast cancer. Jurasunas, Serge Report Apr 1, 2011 2745
FDA clears Bristol-Myers' YERVOY for treatment of metastatic melanoma. Mar 28, 2011 197
Bone drug may help prevent spread of early lung cancer. Feb 27, 2011 259
FDA grants Genentech hearing on Avastin's use for mBC. Feb 25, 2011 128
Singapore HSA clears Eisai's Halaven for treatment of metastatic breast cancer. Disease/Disorder overview Feb 10, 2011 251
Emerging oral therapies for multiple sclerosis. Miller, Colleen E.; Umhauer, Margaret A. Report Feb 1, 2011 7701
Centocor Ortho Biotech seeks FDA nod for abiraterone acetate for metastatic advanced prostate cancer treatment. Dec 21, 2010 212
-FDA advisers support AstraZeneca's NDA for thyroid cancer drug. Dec 3, 2010 241
-FDA advisers support AstraZeneca's NDA for thyroid cancer drug. Dec 3, 2010 242
Anti-angiogenic effect of siphonaxanthin from green alga, Codium fragile. Ganesan, Ponesakki; Matsubara, Kiminori; Ohkubo, Takeshi; Tanaka, Yukihisa; Noda, Kenji; Sugawara, T Dec 1, 2010 4459
Cancer drug developer Exelixis Inc (South San Francisco CA) said interim data from two mid-stage trials of an experimental drug showed promise in patients with a type of prostate cancer and ovarian cancer, sending its shares up 31% for the week. Nov 22, 2010 471
Eisai's Halaven Injection gains FDA nod for treatment of metastatic breast cancer. Nov 16, 2010 322
-AstraZeneca abandons registration plans for prostate cancer drug. Sep 27, 2010 159
AstraZeneca secures FDA approval for 500mg dose of FASLODEX Injection for metastatic breast cancer. Sep 13, 2010 169
Path emerging for tailored metastatic melanoma Tx. Sullivan, Michele G. Sep 1, 2010 493
Sanofi-aventis gets FDA nod for Taxotere Injection Concentrate. Aug 5, 2010 199
United Kingdom : Two new cancer treatments approved for use in the NHS. Jul 28, 2010 301
United States : Sanofi Launches Cancer Treatment. Jul 27, 2010 221
Aromatase inhibitors and bone health. Bundred, Nigel J. Clinical report Jul 1, 2010 4209
Cardiac health following drug treatment for breast cancer. Verrill, Mark Jul 1, 2010 3407
Sanofi-aventis announces FDA approval of Jevtana injection. Jun 18, 2010 210
Bone drug may help fight breast cancer. Jun 4, 2010 463
Drugs show action against the worst prostate cancer: experimental therapies may improve survival in men with aggressive disease that's resistant to standard treatments. Dreicer, Robert Jun 1, 2010 686
Vical Inc (San Diego CA) reported positive data from a mid-stage trial of its experimental treatment for metastatic melanoma, a potentially fatal type of skin cancer, sending its shares up 10% for the week. May 17, 2010 214
Bavarian Nordic says PROSTVAC gains FDA Fast Track status for mCRPC treatment. Apr 29, 2010 205
AstraZeneca says cancer drug misses target in Phase III trial. Mar 8, 2010 219
AstraZeneca says cancer drug misses target in Phase III trial. Mar 8, 2010 221
Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies. Saif, M. Wasif; Lansigan, F.; Ruta, S.; Lamb, L.; Mezes, M.; Elligers, K.; Grant, N.; Jiang, Z.-L.; Report Mar 1, 2010 7273
GlaxoSmithKline announces accelerated approval for TYKERB for metastatic breast cancer. Feb 1, 2010 179
GlaxoSmithKline announces accelerated approval for TYKERB for metastatic breast cancer. Feb 1, 2010 153
Amgen to present results from two pivotal Phase III studies of Vectibix. Jan 21, 2010 221
Sopherion gains FDA Fast Track Designation for Myocet. Jan 7, 2010 165
AstraZeneca announces data from a Phase III study of fulvestrant in postmenopausal women. Dec 14, 2009 305
New hope for cancer drug that crosses blood-brain barrier. Dec 1, 2009 147
Personalized medicine in advanced urothelial cancer: when to treat, how to treat and who to treat. Ehdaie, Behfar; Smith, Steven C.; Theodorescu, Dan Report Dec 1, 2009 4391
Drug That Crosses Blood-Brain Barrier Reduces Formation of Brain Metastases in Mice. Sep 29, 2009 170
SHORT-COURSE RADIOTHERAPY EFFECTIVE FOR BONE METASTASES. Jul 1, 2009 621
Drug shows promise in treating drug-resistant prostate cancer. Jun 1, 2009 188
Triple drug therapy shows promise in treating breast cancer. May 16, 2009 287
Novel drug shows promise in treating drug-resistant prostate cancer. Apr 11, 2009 247
Novel drug shows promise in treating drug-resistant prostate cancer. Apr 9, 2009 247
Novel drug shows promise in treating drug-resistant prostate cancer. Apr 8, 2009 247
Cancer drug hope. Dec 15, 2008 84
Popular cancer drug 'increases blood clot risk'. Dec 3, 2008 458

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters